Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Yoon

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|July 2, 2020
CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancerJian-Xian Lin, Changhwan Yoon, Ping Li, et al.
Annals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.
British Journal of Cancer|January 20, 2026
Retraction Note: CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancerJian-Xian Lin, Changhwan Yoon, Ping Li, et al.
Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcomaKiran Devisetty, Wendy Kobayashi, Herman D Suit, et al.
International Journal of Cancer|June 12, 2012
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1αYeo-Jung Kim, Hae-June Lee, Tae-Min Kim, et al.
Annals of Surgical Oncology|December 28, 2013
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancersDo Joong Park, Changhwan Yoon, Nicholas Thomas, et al.
JAMA Surgery|September 30, 2020
Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open GastrectomiesElvira L Vos, Erin E Salo-Mullen, Laura H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2014
Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculatureHae-June Lee, Changhwan Yoon, Do Joong Park, et al.
Annals of Surgical Oncology|March 5, 2009
Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomasUgwuji N Maduekwe, Francis J Hornicek, Dempsey S Springfield, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|July 2, 2020
CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancerJian-Xian Lin, Changhwan Yoon, Ping Li, et al.
Annals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.
British Journal of Cancer|January 20, 2026
Retraction Note: CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancerJian-Xian Lin, Changhwan Yoon, Ping Li, et al.
Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcomaKiran Devisetty, Wendy Kobayashi, Herman D Suit, et al.
International Journal of Cancer|June 12, 2012
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1αYeo-Jung Kim, Hae-June Lee, Tae-Min Kim, et al.
Annals of Surgical Oncology|December 28, 2013
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancersDo Joong Park, Changhwan Yoon, Nicholas Thomas, et al.
JAMA Surgery|September 30, 2020
Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open GastrectomiesElvira L Vos, Erin E Salo-Mullen, Laura H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2014
Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculatureHae-June Lee, Changhwan Yoon, Do Joong Park, et al.
Annals of Surgical Oncology|March 5, 2009
Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomasUgwuji N Maduekwe, Francis J Hornicek, Dempsey S Springfield, et al.
Pageof 21